FY2026 Earnings Forecast for TSE:FRX Issued By HC Wainwright
Fennec Pharmaceuticals Inc. (TSE:FRX – Free Report) – Analysts at HC Wainwright increased their FY2026 EPS estimates for Fennec Pharmaceuticals in a note issued to investors on Tuesday, May 20th. HC Wainwright analyst R. Selvaraju now anticipates that the biopharmaceutical company will post earnings per share of $0.92 for the year, up from their prior […]
